openPR Logo
Press release

Opioid Withdrawal Syndrome Market Trends, Revenue, Key Suppliers, and Demand, and Forecast till 2031 - USWM, LLC, Teva Pharmaceuticals USA, Inc., Braeburn Inc.

11-13-2024 12:29 PM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Opioid Withdrawal Syndrome Market

Opioid Withdrawal Syndrome Market

The Opioid Withdrawal Syndrome Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/opioid-withdrawal-syndrome-market

What is the projected growth rate (CAGR) of the Global Opioid Withdrawal Syndrome market from 2024 to 2031, and what is the market value expected to change by 2031?

The Opioid Withdrawal Syndrome Market is valued at a significant CAGR during the forecast period (2024-2031).

Opioid withdrawal syndrome refers to the group of symptoms experienced by individuals when they suddenly reduce or stop using opioids after prolonged use or dependence. Symptoms can include nausea, vomiting, diarrhea, muscle aches, anxiety, and irritability. Treatment typically involves supportive care, including hydration, pain management, and medications like methadone or buprenorphine to reduce withdrawal severity. Psychological support, therapy, and detoxification programs are also essential for recovery. Managing opioid withdrawal effectively is a critical component of addiction treatment and rehabilitation to prevent relapse and promote long-term recovery.

Key Developments:

❁ In May 2023, the U.S. Food and Drug Administration (FDA) approved Brixadi (buprenorphine) as an extended-release injection for subcutaneous use in treating moderate to severe opioid use disorder (OUD). This approval provides a new treatment option designed to support individuals with OUD by maintaining therapeutic levels of buprenorphine in the bloodstream over time, potentially improving adherence and reducing the need for daily medication. Brixadi can be administered weekly or monthly, offering flexible dosing to meet diverse patient needs. This new treatment approach aims to enhance the management of OUD and contribute to ongoing efforts in combating the opioid crisis.

List of the Key Players in the Opioid Withdrawal Syndrome Market:

USWM, LLC, Teva Pharmaceuticals USA, Inc., Braeburn Inc, Rosemont Pharmaceuticals Ltd, Mallinckrodt, Pfizer Inc, Alkermes, Inc, Vista Pharm LLC, Steris Healthcare Pvt Ltd, Accord Healthcare Inc.

Research Process:

Both primary and secondary data sources have been used in the global Opioid Withdrawal Syndrome Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Segment Covered in the Opioid Withdrawal Syndrome Market:

By Drug Type: Lucemyra, Methadone, Buprenorphine, Naltrexone, Others.

By Route of Administration: Oral, Intravenous.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Regional Breakout:

The global Opioid Withdrawal Syndrome Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

✫ North America (U.S., Canada, Mexico)

✫ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

✫ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

✫ South America (Colombia, Brazil, Argentina, Rest of South America)

✫ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Get Year End Discounts on Premium Report:- https://www.datamintelligence.com/buy-now-page?report=opioid-withdrawal-syndrome-market

This Report Unveils:

✔ Go to Market Strategy- A roadmap to successfully product launch or service in the target market.

✔ Gain a clear picture of the market's health and growth trajectory through neutral analysis.

✔ Deep Market Insights delve into development trends, competitor landscape, supply and demand dynamics, brand share & pricing analysis year-over-year growth patterns, and key players' performance.

✔ Upon request, we can provide customized reports focusing on specific regions or countries, offering a granular view of their markets.

✔ Identify high-potential niche segments and regions poised for significant expansion.

✔ Analysis of Market Size (historical and forecast) Total Addressable Market (TAM), Serviceable Available Market (SAM), and Serviceable Obtainable Market (SOM) to understand the market's overall size and your achievable market share.

✔ Gain a comprehensive understanding of the competitive landscape, including market share distribution, key players (innovators, startups, laggards, and pioneers), and their respective strengths and weaknesses.

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Opioid Withdrawal Syndrome manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Opioid Withdrawal Syndrome in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the Opioid Withdrawal Syndrome market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the Opioid Withdrawal Syndrome market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Get Customization in the report as per your requirements:- https://datamintelligence.com/customize/opioid-withdrawal-syndrome-market

Frequently Asked Questions

☞ What is the expected growth rate of the global Opioid Withdrawal Syndrome market for the forecast period?

☞ What are the key driving factors that are responsible to shape the fate of the Opioid Withdrawal Syndrome market during the forecast period?

☞ What will be the overall size of the market during the analysis period?

☞ What are the prominent market trends which influence the development of the Opioid Withdrawal Syndrome market across various regions?

☞ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?

☞ What are the challenges and threats that are likely to act as a barrier to the growth of the Opioid Withdrawal Syndrome market?

☞ What are the major opportunities that the companies can get to attain success in the world?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Opioid Withdrawal Syndrome Market Trends, Revenue, Key Suppliers, and Demand, and Forecast till 2031 - USWM, LLC, Teva Pharmaceuticals USA, Inc., Braeburn Inc. here

News-ID: 3733325 • Views:

More Releases from DataM Intelligence 4market Research LLP

United States Pet Supplements Market Forecast 2025-2033: Vitamins, Minerals, Probiotics, and Nutraceuticals Driving Pet Health, Joint Support, Immunity, and Digestive Wellness | Now Foods, Nutramax Laboratories Consumer Care, Inc., Zesty Paws
United States Pet Supplements Market Forecast 2025-2033: Vitamins, Minerals, Pro …
The global pet supplements market reached US$ 2.40 billion in 2023, with a rise to US$ 2.52 billion in 2024, and is expected to reach US$ 4.07 billion by 2033, growing at a CAGR of 6.2% during the forecast period 2025-2033 The pet supplements market involves vitamins, minerals, probiotics, and nutraceuticals designed to enhance the health and wellbeing of pets. Supplements support joint health, digestion, immunity, and skin & coat health
United States Protective Film Market Insights 2025: Detailed Analysis of Material Types, Coating Technologies, Thickness Variations, and Application Across Metals, Glass, Textiles, and Plastics
United States Protective Film Market Insights 2025: Detailed Analysis of Materia …
The Global Protective film Market is expected to grow at a CAGR of 5.1% during the forecasting period (2024-2031). The protective film market includes thin layers of polymeric materials applied to surfaces to prevent damage during manufacturing, transport, or usage. Films are used in electronics, automotive, construction, and packaging industries to protect against scratches, dust, moisture, and UV exposure. Market growth is driven by increased demand for durable consumer goods and
United States Surgical Robotics Market Forecast 2024-2033: Market Size, Competitive Landscape, AI Integration, and Opportunities Across Urology, Cardiology, Orthopedics, and General Surgery
United States Surgical Robotics Market Forecast 2024-2033: Market Size, Competit …
The global surgical robotics market reached US$ 5.84 Billion in 2024 and is expected to reach US$ 15.25 Billion by 2033, growing at a CAGR of 11.3% during the forecast period 2025-2033. The surgical robotics market involves robotic systems that assist surgeons in performing minimally invasive and complex procedures with precision. Applications include urology, cardiology, orthopedics, and general surgery. Market growth is driven by rising demand for minimally invasive surgeries, technological
United States Diameter Signaling Market (2024-2031): Trends, Protocols, and Telecom Applications | Oracle Corporation, Huawei Technologies Co. Ltd, Telefonaktiebolaget LM Ericsson
United States Diameter Signaling Market (2024-2031): Trends, Protocols, and Tele …
The Diameter Signaling Market is valued at at a high CAGR during the forecast period (2024-2031). The diameter signaling market focuses on communication protocols used in telecommunications networks for authentication, authorization, and accounting functions. It is widely adopted in mobile networks, IMS, LTE, and 5G infrastructures. Market growth is driven by the rapid expansion of mobile broadband, VoLTE, and IoT networks. Diameter signaling ensures secure and reliable data transfer between network

All 5 Releases


More Releases for Opioid

Rising Opioid Use For Pain Management Fuels Growth In Opioid-Induced Constipatio …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Opioid-Induced Constipation Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for treatment of opioid-induced constipation has seen a substantial growth recently. It is expected to escalate from a solid $1.78 billion in 2024 to an impressive $1.9 billion in 2025, exhibiting
Growing Number Of Opioid Addiction Cases: Strategic Insights Driving Opioid Use …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Opioid Use Disorder (OUD) Market Size By 2025? The market size for opioid use disorder (OUD) has experienced a quick expansion in the past few years. The growth is projected to rise from $3.96 billion in 2024 to $4.39 billion in 2025, boasting a compound
Key Influencer in the Opioid-Induced Constipation Treatment Market 2025: Rising …
What combination of drivers is leading to accelerated growth in the opioid-induced constipation treatment market? The rise in opioid administration for cancer and non-cancer pain is expected to drive the growth of the opioid-induced constipation (OIC) treatment market. Opioids are commonly used for managing moderate to severe pain, but they can cause constipation. OIC treatments are vital for improving the quality of life for patients on opioids, allowing them to maintain
Top Factor Driving Opioid Use Disorder (OUD) Market Growth in 2025: Growing Numb …
How Are the key drivers contributing to the expansion of the opioid use disorder (oud) market? The rise in instances of opioid dependency is set to fuel the expansion of the opioid use disorder (OUD) market. Opioid dependency defines a health concern marked by habitual and uncontrolled opioid consumption which negatively impacts health. These opioids can generate feelings of bliss and relief from pain, but continued usage often results in tolerance
What's Driving the Opioid-Induced Constipation Treatment Market 2025-2034: Risin …
What Are the Projections for the Size and Growth Rate of the Opioid-Induced Constipation Treatment Market? The market size for treatments of constipation caused by opioids has seen robust growth lately. The forecasted growth indicates an increase from $1.78 billion in 2024 to $1.9 billion in 2025, representing a compound annual growth rate (CAGR) of 7.0%. This past growth is associated with a growing elderly population, individualized treatments for OIC, the
MEDICAL MARIJUANA AND THE OPIOID CRISIS
Marijuana from the Cannabis plant is classified as a psychoactive drug used for medical or recreational purposes. Although it has been used for decades, in the U.S., it is still illegal under federal law to use and possess marijuana. Get PDF Sample Brochure of this report at: https://decisionmarketreports.com/request-sample/1247622 Nevertheless, at the state level, policies regarding the medical and recreational use of Cannabis vary greatly, and in many states conflict significantly with federal